Vol 25, No 5 (2018)
Original articles — Basic science and experimental cardiology
Published online: 2017-12-01

open access

Page views 2076
Article views/downloads 1443
Get Citation

Connect on Social Media

Connect on Social Media

Variant rs2200733 and rs10033464 on chromosome 4q25 are associated with increased risk of atrial fibrillation after catheter ablation: Evidence from a meta-analysis

Jiake He, Wengen Zhu, Yang Yu, Jinzhu Hu, Kui Hong
Pubmed: 29240960
Cardiol J 2018;25(5):628-638.


Background: Common genetic polymorphisms at chromosome 4q25 were associated with increased susceptibility to atrial fibrillation (AF). However, it remained controversial whether these variants could be used as risk predictors for AF recurrence after catheter ablation. We therefore performed a metaanalysis to quantify the association between rs2200733 C>T/rs10033464 G>T and AF recurrence.

Methods: Relevant studies were systematically retrieved from PubMed, Web of Science, Elsevier database and Cochrane library through November 2016. Data were abstracted and pooled using Stata 12.0 software.

Results: A total of 2,145 patients undergoing catheter ablation were included. Patients with rs2200733 TT or TT+CT showed an overall increased susceptibility to AF recurrence (homozygous model [TT vs. CC]: odds ratio [OR] = 2.03, 95% confidence interval [CI] 1.49–2.76, p = 0.000; dominant model [TT+TC vs. CC]: OR = 1.48, 95% CI 1.17–1.87, p = 0.001; recessive model [TT vs. TC+CC]: OR = 1.88, 95% CI 1.12–3.15, p = 0.017). Subgroup analysis also identified a positive relation in Caucasians and late recurrence of AF in allelic, homozygous and dominant comparison. Moreover, a significant increased risk of AF recurrence was observed in patients with rs10033464 TG or TT+TG (heterozygous model [TG vs. GG]: OR = 1.46, 95% CI 1.01–2.12, p = 0.047; dominant model [TT+TG vs. GG]: OR = 1.51, 95% CI 1.04–2.17, p = 0.029).

Conclusions: After catheter ablation, rs2200733 (TT or TT+TC) and rs10033464 (TT+TG or TG) were associated with increased risk of AF recurrence.

Article available in PDF format

View PDF Download PDF file


  1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014; 129(8): 837–847.
  2. Zhu W, Yuan P, Shen Y, et al. Association of smoking with the risk of incident atrial fibrillation: A meta-analysis of prospective studies. Int J Cardiol. 2016; 218: 259–266.
  3. Piccini JP, Simon DN, Steinberg BA, et al. Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry. JAMA Cardiol. 2016; 1(3): 282–291.
  4. Phan K, Khuong JN, Xu J, et al. Obesity and postoperative atrial fibrillation in patients undergoing cardiac surgery: Systematic review and meta-analysis. Int J Cardiol. 2016; 217: 49–57.
  5. Gudbjartsson DF, Arnar DO, Helgadottir A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature. 2007; 448(7151): 353–357.
  6. Bhanushali A, Nair A, Jagdale G, et al. Association of Genetic Variants at the 4q25 Locus with Atrial Fibrillation in Indian Population. J Clin Lab Anal. 2017; 31(1).
  7. Ferrán A, Alegret JM, Subirana I, et al. Association between rs2200733 and rs7193343 genetic variants and atrial fibrillation in a Spanish population, and meta-analysis of previous studies. Rev Esp Cardiol (Engl Ed). 2014; 67(10): 822–829.
  8. Olesen MS, Holst AG, Jabbari J, et al. Genetic loci on chromosomes 4q25, 7p31, and 12p12 are associated with onset of lone atrial fibrillation before the age of 40 years. Can J Cardiol. 2012; 28(2): 191–195.
  9. Viviani Anselmi C, Novelli V, Roncarati R, et al. Association of rs2200733 at 4q25 with atrial flutter/fibrillation diseases in an Italian population. Heart. 2008; 94(11): 1394–1396.
  10. Kiliszek M, Franaszczyk M, Kozluk E, et al. Association between variants on chromosome 4q25, 16q22 and 1q21 and atrial fibrillation in the Polish population. PLoS One. 2011; 6(7): e21790.
  11. Lee KT, Yeh HY, Tung CP, et al. Association of RS2200733 but not RS10033464 on 4q25 with atrial fibrillation based on the recessive model in a Taiwanese population. Cardiology. 2010; 116(3): 151–156.
  12. Choi EK, Park JH, Lee JY, et al. Korean Atrial Fibrillation (AF) Network: Genetic Variants for AF Do Not Predict Ablation Success. J Am Heart Assoc. 2015; 4(8): e002046.
  13. Lubitz SA, Sinner MF, Lunetta KL, et al. Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation. 2010; 122(10): 976–984.
  14. Kääb S, Darbar D, van Noord C, et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J. 2009; 30(7): 813–819.
  15. Husser D, Adams V, Piorkowski C, et al. Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2010; 55(8): 747–753.
  16. Zhao LQ, Zhang GB, Wen ZJ, et al. Common variants predict recurrence after nonfamilial atrial fibrillation ablation in Chinese Han population. Int J Cardiol. 2017; 227: 360–366.
  17. Chen F, Yang Y, Zhang R, et al. Polymorphism rs2200733 at chromosome 4q25 is associated with atrial fibrillation recurrence after radiofrequency catheter ablation in the Chinese Han population. Am J Transl Res. 2016; 8(2): 688–697.
  18. Kiliszek M, Kozluk E, Franaszczyk M, et al. The 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation. Arch Med Sci. 2016; 12(1): 38–44.
  19. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9): 603–605.
  20. Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010; 3(1): 32–38.
  21. Kirchhof P, Calkins H. Catheter ablation in patients with persistent atrial fibrillation. Eur Heart J. 2017; 38(1): 20–26.
  22. Björkenheim A, Brandes A, Chemnitz A, et al. Rhythm control and its relation to symptoms during the first two years after radiofrequency ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2016; 39(9): 914–925.
  23. Tzou WS, Marchlinski FE, Zado ES, et al. Long-term outcome after successful catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2010; 3(3): 237–242.
  24. Winkle RA, Jarman JWE, Mead RH, et al. Predicting atrial fibrillation ablation outcome: The CAAP-AF score. Heart Rhythm. 2016; 13(11): 2119–2125.
  25. Li N, Dobrev D, Wehrens XHT. PITX2: a master regulator of cardiac channelopathy in atrial fibrillation? Cardiovasc Res. 2016; 109(3): 345–347.
  26. Shoemaker MB, Bollmann A, Lubitz SA, et al. Common genetic variants and response to atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2015; 8(2): 296–302.
  27. Mommersteeg MTM, Brown NA, Prall OWJ, et al. Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res. 2007; 101(9): 902–909.
  28. Syeda F, Holmes AP, Yu TY, et al. PITX2 modulates atrial membrane potential and the antiarrhythmic effects of sodium-channel blockers. J Am Coll Cardiol. 2016; 68(17): 1881–1894.
  29. Kirchhof P, Kahr PC, Kaese S, et al. PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circ Cardiovasc Genet. 2011; 4(2): 123–133.
  30. Wang J, Klysik E, Sood S, et al. Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proc Natl Acad Sci U S A. 2010; 107(21): 9753–9758.
  31. Lozano-Velasco E, Hernández-Torres F, Daimi H, et al. Pitx2 impairs calcium handling in a dose-dependent manner by modulating Wnt signalling. Cardiovasc Res. 2016; 109(1): 55–66.
  32. Pérez-Hernández M, Matamoros M, Barana A, et al. Pitx2c increases in atrial myocytes from chronic atrial fibrillation patients enhancing IKs and decreasing ICa,L. Cardiovasc Res. 2016; 109(3): 431–441.
  33. Chinchilla A, Daimi H, Lozano-Velasco E, et al. PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. Circ Cardiovasc Genet. 2011; 4(3): 269–279.
  34. Benjamin Shoemaker M, Muhammad R, Parvez B, et al. Common atrial fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial fibrillation ablation. Heart Rhythm. 2013; 10(3): 394–400.
  35. Ye J, Tucker NR, Weng LC, et al. A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a. Am J Hum Genet. 2016; 99(6): 1281–1291.
  36. Gore-Panter SR, Hsu J, Barnard J, et al. PANCR, the PITX2 Adjacent Noncoding RNA, Is Expressed in Human Left Atria and Regulates PITX2c Expression. Circ Arrhythm Electrophysiol. 2016; 9(1): e003197.
  37. Huang Y, Wang C, Yao Y, et al. Molecular Basis of Gene-Gene Interaction: Cyclic Cross-Regulation of Gene Expression and Post-GWAS Gene-Gene Interaction Involved in Atrial Fibrillation. PLoS Genet. 2015; 11(8): e1005393.